US Stock MarketDetailed Quotes

EWTX Edgewise Therapeutics

Watchlist
  • 27.620
  • -0.530-1.88%
Close Dec 13 16:00 ET
  • 28.750
  • +1.130+4.09%
Post 20:01 ET
2.62BMarket Cap-18.41P/E (TTM)

Edgewise Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-24.10%-27.37M
-28.99%-26.1M
-25.29%-28.6M
-74.69%-91.95M
-126.32%-26.83M
-84.39%-22.06M
-24.56%-20.23M
-81.56%-22.83M
-57.09%-52.64M
-25.86%-11.86M
Net income from continuing operations
-32.73%-34.13M
-46.71%-31.5M
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-57.99%-67.64M
-52.92%-19.42M
Depreciation and amortization
21.13%602K
15.84%534K
117.84%525K
221.93%1.73M
479.35%533K
201.21%497K
199.35%461K
89.76%241K
97.79%538K
17.95%92K
Change In working capital
158.01%2.51M
1,033.63%3.19M
-16.47%-2.32M
-138.18%-1.56M
-103.66%-201K
-52.95%974K
87.72%-342K
-189.81%-1.99M
-11.75%4.09M
313.80%5.49M
-Change in prepaid assets
168.37%791K
158.93%977K
82.45%-63K
-144.70%-3.55M
-235.84%-379K
-508.95%-1.16M
14.49%-1.66M
-190.20%-359K
39.30%-1.45M
163.27%279K
-Change in payables and accrued expense
-14.91%1.9M
81.38%2.39M
-19.68%-2.09M
-19.90%2.1M
-91.40%295K
88.68%2.23M
248.20%1.32M
-57.62%-1.75M
-62.72%2.62M
94.17%3.43M
-Change in other current liabilities
-73.79%-179K
---171K
-241.38%-164K
-103.56%-104K
-106.58%-117K
-109.57%-103K
--0
383.33%116K
--2.92M
--1.78M
Cash from discontinued investing activities
Operating cash flow
-24.10%-27.37M
-28.99%-26.1M
-25.29%-28.6M
-74.69%-91.95M
-126.32%-26.83M
-84.39%-22.06M
-24.56%-20.23M
-81.56%-22.83M
-57.09%-52.64M
-25.86%-11.86M
Investing cash flow
Cash flow from continuing investing activities
8.30%25.36M
985.65%37.37M
-647.10%-268.31M
245.78%102.89M
135.69%26.98M
188.97%23.42M
7,582.61%3.44M
56.25%49.04M
70.86%-70.58M
-635.34%-75.6M
Net PPE purchase and sale
-13.79%-520K
70.88%-221K
93.20%-297K
-3.59%-5.75M
95.11%-161K
65.64%-457K
-37.00%-759K
-1,083.74%-4.37M
-730.24%-5.55M
-4,068.35%-3.29M
Net investment purchase and sale
8.40%25.88M
794.76%37.59M
-601.80%-268.01M
267.04%108.63M
137.54%27.14M
195.54%23.88M
726.97%4.2M
68.19%53.41M
73.08%-65.03M
-609.18%-72.3M
Cash from discontinued investing activities
Investing cash flow
8.30%25.36M
985.65%37.37M
-647.10%-268.31M
245.78%102.89M
135.69%26.98M
188.97%23.42M
7,582.61%3.44M
56.25%49.04M
70.86%-70.58M
-635.34%-75.6M
Financing cash flow
Cash flow from continuing financing activities
1,679.62%3.33M
429.00%1.95M
1,147,866.67%241.07M
-58.99%53.17M
17,587.46%52.99M
-100.16%-211K
106.15%369K
-71.23%21K
-30.45%129.64M
-203.41%-303K
Net common stock issuance
--0
--0
--239.15M
-59.26%52.62M
9,580.72%52.62M
--0
--0
--0
-30.61%129.17M
---555K
Proceeds from stock option exercised by employees
118,133.33%3.55M
442.01%2M
9,071.43%1.93M
-1.66%713K
91.62%320K
-94.23%3K
-14.78%369K
-71.23%21K
101.39%725K
-43.00%167K
Net other financing activities
---214K
----
----
34.26%-165K
-42.35%49K
----
----
----
-102.42%-251K
--85K
Cash from discontinued financing activities
Financing cash flow
1,679.62%3.33M
429.00%1.95M
1,147,866.67%241.07M
-58.99%53.17M
17,587.46%52.99M
-100.16%-211K
106.15%369K
-71.23%21K
-30.45%129.64M
-203.41%-303K
Net cash flow
Beginning cash position
36.72%43.49M
-37.25%30.26M
291.47%86.1M
41.29%21.99M
-69.97%32.96M
73.42%31.81M
39.99%48.23M
41.29%21.99M
-85.16%15.57M
938.19%109.75M
Current changes in cash
14.87%1.32M
180.50%13.22M
-312.80%-55.83M
897.42%64.1M
160.56%53.14M
-98.74%1.15M
-1.93%-16.42M
38.92%26.24M
107.19%6.43M
-1,856.84%-87.75M
End cash Position
35.95%44.81M
36.72%43.49M
-37.25%30.26M
291.47%86.1M
291.47%86.1M
-69.97%32.96M
73.42%31.81M
39.99%48.23M
41.29%21.99M
41.29%21.99M
Free cash flow
-23.89%-27.89M
-25.38%-26.32M
-6.26%-28.9M
-67.91%-97.69M
-78.18%-26.99M
-69.37%-22.52M
-24.97%-20.99M
-110.14%-27.19M
-70.24%-58.18M
-59.49%-15.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -24.10%-27.37M-28.99%-26.1M-25.29%-28.6M-74.69%-91.95M-126.32%-26.83M-84.39%-22.06M-24.56%-20.23M-81.56%-22.83M-57.09%-52.64M-25.86%-11.86M
Net income from continuing operations -32.73%-34.13M-46.71%-31.5M-24.90%-28.53M-48.08%-100.16M-55.26%-30.14M-46.95%-25.71M-33.62%-21.47M-55.78%-22.84M-57.99%-67.64M-52.92%-19.42M
Depreciation and amortization 21.13%602K15.84%534K117.84%525K221.93%1.73M479.35%533K201.21%497K199.35%461K89.76%241K97.79%538K17.95%92K
Change In working capital 158.01%2.51M1,033.63%3.19M-16.47%-2.32M-138.18%-1.56M-103.66%-201K-52.95%974K87.72%-342K-189.81%-1.99M-11.75%4.09M313.80%5.49M
-Change in prepaid assets 168.37%791K158.93%977K82.45%-63K-144.70%-3.55M-235.84%-379K-508.95%-1.16M14.49%-1.66M-190.20%-359K39.30%-1.45M163.27%279K
-Change in payables and accrued expense -14.91%1.9M81.38%2.39M-19.68%-2.09M-19.90%2.1M-91.40%295K88.68%2.23M248.20%1.32M-57.62%-1.75M-62.72%2.62M94.17%3.43M
-Change in other current liabilities -73.79%-179K---171K-241.38%-164K-103.56%-104K-106.58%-117K-109.57%-103K--0383.33%116K--2.92M--1.78M
Cash from discontinued investing activities
Operating cash flow -24.10%-27.37M-28.99%-26.1M-25.29%-28.6M-74.69%-91.95M-126.32%-26.83M-84.39%-22.06M-24.56%-20.23M-81.56%-22.83M-57.09%-52.64M-25.86%-11.86M
Investing cash flow
Cash flow from continuing investing activities 8.30%25.36M985.65%37.37M-647.10%-268.31M245.78%102.89M135.69%26.98M188.97%23.42M7,582.61%3.44M56.25%49.04M70.86%-70.58M-635.34%-75.6M
Net PPE purchase and sale -13.79%-520K70.88%-221K93.20%-297K-3.59%-5.75M95.11%-161K65.64%-457K-37.00%-759K-1,083.74%-4.37M-730.24%-5.55M-4,068.35%-3.29M
Net investment purchase and sale 8.40%25.88M794.76%37.59M-601.80%-268.01M267.04%108.63M137.54%27.14M195.54%23.88M726.97%4.2M68.19%53.41M73.08%-65.03M-609.18%-72.3M
Cash from discontinued investing activities
Investing cash flow 8.30%25.36M985.65%37.37M-647.10%-268.31M245.78%102.89M135.69%26.98M188.97%23.42M7,582.61%3.44M56.25%49.04M70.86%-70.58M-635.34%-75.6M
Financing cash flow
Cash flow from continuing financing activities 1,679.62%3.33M429.00%1.95M1,147,866.67%241.07M-58.99%53.17M17,587.46%52.99M-100.16%-211K106.15%369K-71.23%21K-30.45%129.64M-203.41%-303K
Net common stock issuance --0--0--239.15M-59.26%52.62M9,580.72%52.62M--0--0--0-30.61%129.17M---555K
Proceeds from stock option exercised by employees 118,133.33%3.55M442.01%2M9,071.43%1.93M-1.66%713K91.62%320K-94.23%3K-14.78%369K-71.23%21K101.39%725K-43.00%167K
Net other financing activities ---214K--------34.26%-165K-42.35%49K-------------102.42%-251K--85K
Cash from discontinued financing activities
Financing cash flow 1,679.62%3.33M429.00%1.95M1,147,866.67%241.07M-58.99%53.17M17,587.46%52.99M-100.16%-211K106.15%369K-71.23%21K-30.45%129.64M-203.41%-303K
Net cash flow
Beginning cash position 36.72%43.49M-37.25%30.26M291.47%86.1M41.29%21.99M-69.97%32.96M73.42%31.81M39.99%48.23M41.29%21.99M-85.16%15.57M938.19%109.75M
Current changes in cash 14.87%1.32M180.50%13.22M-312.80%-55.83M897.42%64.1M160.56%53.14M-98.74%1.15M-1.93%-16.42M38.92%26.24M107.19%6.43M-1,856.84%-87.75M
End cash Position 35.95%44.81M36.72%43.49M-37.25%30.26M291.47%86.1M291.47%86.1M-69.97%32.96M73.42%31.81M39.99%48.23M41.29%21.99M41.29%21.99M
Free cash flow -23.89%-27.89M-25.38%-26.32M-6.26%-28.9M-67.91%-97.69M-78.18%-26.99M-69.37%-22.52M-24.97%-20.99M-110.14%-27.19M-70.24%-58.18M-59.49%-15.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data